Skip to main content
Signal8

New Enterprise Associates 17, L.P.

SEC insider (Form 3/4/5 filer). CIK 0001768564. 10% Owner at Korro Bio, Inc. (KRRO) and 3 other issuers. 16 reported Form 4/5 transactions since Sep 2024; latest on Mar 10, 2026. Located in TIMONIUM, MD.

Companies New Enterprise Associates 17, L.P. has filed insider reports for

  • Korro Bio, Inc. (KRRO): 10% Owner
  • SpyGlass Pharma, Inc. (SGP): 10% Owner
  • NeueHealth, Inc. (NEUE): 10% Owner
  • MBX Biosciences, Inc. (MBX): 10% Owner
New Enterprise Associates 17, L.P. profile photo

New Enterprise Associates 17, L.P.

CIK: 0001768564

Transaction Breakdown

Open Market Buys (P)4 (25.0%)

High conviction signal

Open Market Sales (S)1 (6.3%)

Position reduction

Option Exercises (M)1 (6.3%)

Derivative conversions

Awards (A)1 (6.3%)

Compensation grants

Other (G, F, J, C, D, …)9 (56.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (4)

Korro Bio, Inc. logo
KRRO

Korro Bio, Inc.

10% Owner
SpyGlass Pharma, Inc. logo
SGP

SpyGlass Pharma, Inc.

10% Owner
NeueHealth, Inc. logo
NEUE

NeueHealth, Inc.

10% Owner
MBX Biosciences, Inc. logo
MBX

MBX Biosciences, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (16 total)

  • Korro Bio, Inc. logo
    KRRO

    Korro Bio, Inc.

    Mar 10, 2026
    Purchase
    Direct
    207.1K shares at avg. $11.11$2.3M
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Conversion
    Direct
    1.6M shares-
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Conversion
    Direct
    1.4M shares-
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Conversion
    Direct
    1.4M shares-
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Conversion
    Direct
    738K shares-
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Purchase
    Direct
    937.5K shares at avg. $16.00$15.0M
  • NeueHealth, Inc. logo
    NEUE

    NeueHealth, Inc.

    Oct 2, 2025
    Award

    Warrant (Right to Buy)

    Direct
    186.1K shares-
  • NeueHealth, Inc. logo
    NEUE

    NeueHealth, Inc.

    Oct 2, 2025
    Sale
    Direct
    280 shares at avg. $6.75$2K
  • NeueHealth, Inc. logo
    NEUE

    NeueHealth, Inc.

    Oct 2, 2025
    Exercise
    Direct
    186.1K shares at avg. $0.01$2K
  • NeueHealth, Inc. logo
    NEUE

    NeueHealth, Inc.

    Oct 2, 2025
    Tax Payment
    Direct
    276 shares at avg. $6.75$2K

1-10 of 16